3//SEC Filing
Pfizer Ventures (US) LLC 3
Accession 0000078003-19-000070
CIK 0001773427other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 4:55 PM ET
Size
9.5 KB
Accession
0000078003-19-000070
Insider Transaction Report
Form 3
PFIZER INC
10% Owner
Holdings
Series B Convertible Preferred Stock
→ Common Stock (526,602 underlying)Junior Series A Convertible Preferred Stock
→ Common Stock (978,194 underlying)Series A Convertible Preferred Stock
→ Common Stock (3,039,051 underlying)
Pfizer Ventures (US) LLC
10% Owner
Holdings
Junior Series A Convertible Preferred Stock
→ Common Stock (978,194 underlying)Series A Convertible Preferred Stock
→ Common Stock (3,039,051 underlying)Series B Convertible Preferred Stock
→ Common Stock (526,602 underlying)
Footnotes (4)
- [F1]Each share of Junior Series A Convertible Preferred Stock is convertible into shares of the Issuer's Common Stock on a 6.5810:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Junior Series A Convertible Preferred Stock will convert into shares of Common Stock of the Issuer. The Junior Series A Convertible Preferred Stock has no expiration date. Such shares are held of record by Pfizer Inc. ("Pfizer").
- [F2]Each share of Series A Convertible Preferred Stock is convertible into shares of the Issuer's Common Stock on a 6.5810:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock will convert into shares of Common Stock of the Issuer. The Series A Convertible Preferred Stock has no expiration date. Such shares are held of record by Pfizer.
- [F3]Each share of Series B Convertible Preferred Stock is convertible into shares of the Issuer's Common Stock on a 6.5810:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Convertible Preferred Stock will convert into shares of Common Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date. Such shares are held of record by Pfizer Ventures (US) LLC, a wholly-owned subsidiary of Pfizer.
- [F4]Each Reporting Person disclaims ownership of securities held by each other Reporting Person, except to the extent of its respective pecuniary interest therein.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001776087
Filing Metadata
- Form type
- 3
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 4:55 PM ET
- Size
- 9.5 KB